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The performance of the VersaTREK blood culture system for the detection of a bacterial contamination of
platelet concentrates was assessed using samples spiked with serial dilutions of nine bacterial species asso-
ciated with platelet contamination. The system detected growth for all organisms in <20 h, and the detection
sensitivity was <20 CFU/ml.
Four million platelet concentrates (PLT) are transfused in
the United States annually. To preserve their function, PLT
are stored at 20 to 24°C—a range that also permits bacterial
growth (4). Bacterial contamination is reported to occur in 1 in
1,000 to 2,000 PTL units (4). A study conducted by the Red
Cross over 26 months found that the PLT contamination rate
was 1:5,399 units and that PLT contamination resulted in 20
septic reactions, including three fatalities (6).
To limit adverse events, the American Association of Blood
Banks (AABB) mandated that member institutions adopt
measures to detect bacterial contamination in PLT (1). Of the
commercially available automated microbial detection systems,
only the BacT/Alert (bioMe´rieux, Durham, NC) and the Pall
eBDS (Pall Corporation, East Hills, NY) systems received
FDA clearance for the quality control (QC) testing of PLT,
necessitating that laboratories using other systems perform
in-house verification studies (7). To this end, we evaluated the
Bactec 9240 system (BD Microbiology, Cockeysville, MD)
prior to using it for the detection of PLT contamination in our
facility by using single-donor PLT spiked with dilutions of nine
species of bacteria commonly associated with PLT contamina-
tion (2, 3, 5, 9). The Bactec system was found to have a
detection limit of 10 CFU/ml for all but one test organism
(Streptococcus mitis) and detected growth in 18 h.
When the VersaTREK system (TREK Diagnostic Systems,
Cleveland, OH) replaced the Bactec 9240 system in our labo-
ratory as our primary blood culture system, the PLT protocol
used previously was repeated and the results are presented
here. VersaTREK monitors bacterial growth by detecting pres-
sure changes in the headspace of the blood culture bottle
secondary to gas consumption/production.
Nine bacterial species, including Escherichia coli (ATCC
35922), Pseudomonas aeruginosa (ATCC 27853), Staphylococ-
cus aureus (ATCC 14990), Staphylococcus epidermidis (ATCC
14990), and Klebsiella pneumoniae (ATCC 13883) and clinical
isolates of Bacillus cereus, Serratia marcescens, Enterobacter
cloacae, and Streptococcus mitis, were used for the study. The
bacteria were cultured overnight in 10 ml of Trypticase soy
broth with shaking and harvested by centrifugation at 3,000  g
for 5 min. The cells were washed in phosphate-buffered saline,
centrifuged, and suspended in phosphate-buffered saline to
approximate a 0.5 McFarland standard (approximately 1  108
to 5  108 CFU/ml). Tenfold serial dilutions (101 to 1010)
were made from each suspension in single-donor PLT. Blood
culture bottles (VersaTREK Redox 1 [80 ml]; TREK) were
inoculated with 4 ml of each dilution, ranging from 104 to
1010. A blood culture bottle inoculated with 4 ml of the PLT
product served as a negative control. Dilutions ranging from
101 to 103 showed consistent positive growth and were not
included in this study. Inoculated bottles were incubated in the
VersaTREK system for a maximum of 5 days. Signal-positive
bottles were subcultured to blood agar to confirm the identity
of the isolates.
To determine the inoculum size, 0.1 ml of each dilution
was plated in duplicate onto blood agar plates. Colony
counts were obtained after 48 h of incubation, and the
number of organisms injected into each blood culture bottle
was determined (Table 1).
The detection sensitivity of the VersaTREK system was 10
CFU/ml for eight of the nine species tested (Table 1). The
VersaTREK system was the most sensitive for the detection of
S. epidermidis (calculated at 0.025 CFU/ml) and the least sen-
sitive for S. mitis (20 CFU/ml). The highest dilution (lowest
inoculum) of each organism to generate a positive signal did so
in 18.1 h. The range of signal positivity varied from 6.0 h for
S. marcescens (104 dilution; 5.08  104 CFU per ml) to 18.1 h
for S. epidermidis (1010 dilution; 0.025 CFU per ml) (Table 1).
Following this study, the VersaTREK system was introduced
for the routine QC of apheresis PLT using a 4-ml inoculum
volume (Table 2). The products with negative growth after 24 h
of monitoring were released for transfusion but were incubated
for a total of 5 days. Over a 6-month period, 1,970 apheresis
PLT were tested, and 5 were positive for bacterial growth.
Positive cultures included three viridans-group Streptococcus
species, one coagulase-negative Staphylococcus species, and
one Bacillus species. Three of the five positive PLT were de-
tected within 24 h of culture and discarded. The other two were
transfused without evidence of unfavorable outcomes based on
chart review.
* Corresponding author. Mailing address: Department of Pathology
and Immunology, Washington University School of Medicine, 660 S.
Euclid Avenue, Campus Box 8118, St. Louis, MO 63110. Phone: (314)
362-1547. Fax: (314) 362-1461. E-mail: dunne@wustl.edu.
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In 2004, the AABB introduced a standard requiring all
member institutions to implement QC testing of PLT to de-
crease the transfusion of contaminated units (1). Alternatives
for testing included the measurement of pH or glucose level,
microscopy, or culture, and the target level of detection was 10
CFU per ml (2). Although measurements of pH or glucose
level give rapid results, the sensitivity of these methods is poor
(106 to 107 CFU/ml [4]). Two commercial bacterial detection
systems, the BacT/Alert (bioMe´rieux) and the eBDS (Pall),
were shown to detect 10 CFU/ml (4) and received FDA clear-
ance for this application.
However, two additional bacterial detection systems, the
Bactec 9240 (Becton-Dickinson) and the VersaTREK (TREK
Diagnostic) are not FDA cleared for the QC of PLT but are
used in many clinical laboratories as a primary blood culture
system. Under our study conditions, the VersaTREK system
detected 10 CFU/ml for all species tested except Streptococ-
cus mitis (20 CFU/ml), while the time to positivity ranged from
6 to 18 h. Thus, the sensitivity and the rate of detection for
artificially contaminated PLT were nearly identical to that re-
ported for the Bactec 9240 system (5). Recently, Riedel et al.
compared the Bactec 9240 system with the BacT/Alert system
(bioMe´rieux, Durham, NC) for the QC of PLT and showed
that the former detected bacterial contamination in signifi-
cantly less time (10). Taken together, these data indicate that
all three systems are technically capable of performing routine
QC of PLT, yet only one has received clearance for this pur-
pose. Perhaps it would be reasonable to reassess the FDA
clearance process.
After implementation, the VersaTREK system showed an
overall positivity rate of approximately 1 in 394 PLT compared
to 1 in 554 for the Bactec 9240 system (5). The higher fre-
quency of detection of the viridans group Streptococcus by
VersaTREK (three of five positive cultures) compared to that
of the Bactec 9240 system (one of seven positive cultures) (5)
suggests either an increased sensitivity of the former or a
greater propensity for contamination. Mirrett et al. showed a
significant increase in the detection of streptococci and entero-
cocci from blood using VersaTREK compared with that of the
BacT/Alert system (8).
We conclude that VersaTREK is comparable to Bactec 9240
for detecting the low-level contamination of PLT prior to
transfusion.
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TABLE 1. Results of the VersaTREK detection of mock-infected PLT with nine bacterial test strains
Organism (primary inoculum
size CFU/ml)
Time (h) to signal bottle detection for indicated dilutiona Sensitivity of
detection
(CFU/ml)104 105 106 107 108 109 1010
P. aeruginosa (9.21  107) 9.3 11.1 12.3 13.9 15.6 16.4 NG 10
S. aureus (5.4  107) 8.2 9.2 10 11 12.2 12.4 NG 10
E. coli (1.21  108) 6.7 7.5 8.4 9.4 10.4 NG NG 10
S. marcescens (1.27 108) 6 7 7.8 9.2 10.2 11.4 NG 10
S. epidermidis (6.4  107) 9.9 11.6 13.3 14.7 15.7 16.1 18.1 10
K. pneumoniae (1  108) 7.3 8.1 9.4 10.6 11.7 NG NG 10
B. cereus (3.2  107) 6.5 7.3 8.3 8.3 10.3 NG NG 10
E. cloacae (9  107) 7.3 8.3 9.9 10.9 12.5 12.9 NG 10
S. mitis (2  107) 11 13.2 16.4 NG NG NG NG 20
a NG, no growth after 5 days of incubation.
TABLE 2. Positive bacterial culture in apheresis PLT detected by
VersaTREK during the first 6 months (1,970 donors)
Collection date Initial culture date Initial culture result
January 22, 2008 January 22, 2008 Viridans group
Streptococcusa
February 7, 2008 February 8, 2008 Viridans group
Streptococcus
April 23, 2008 April 24, 2008 Coagulase-negative
Staphylococcus
May 14, 2008 May 15, 2008 Bacillus species, not B.
anthracisa
June 7, 2008 June 8, 2008 Viridans group
Streptococcus
a Apheresis PLT transfused before turning positive.
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